{"id":7770,"date":"2025-12-22T15:27:04","date_gmt":"2025-12-22T06:27:04","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4527\/"},"modified":"2026-08-23T13:13:07","modified_gmt":"2026-08-23T04:13:07","slug":"company-4527","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4527\/","title":{"rendered":"ROHTO PHARMACEUTICAL CO"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4527","DATE":"2025-12-22","longName":"Rohto Pharmaceutical Co.,Ltd.","company_name_ja":"","fullTimeEmployees":9292,"address":"","phone":"","website":"https:\/\/www.rohto.co.jp","industry":"Household & Personal Products","sector":"Consumer Defensive","regularMarketPrice":2639.5,"financialCurrency":"","marketCap":596432,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":145.28999999999999,"epsForward":0,"bookValue":0,"totalRevenue":343725000000,"OperatingIncome":41122000000,"operatingMargins":11.960000000000001,"NetIncome":34247000000,"profitMargins":9.9600000000000009,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":11.35,"recommendationMean":1.90909,"recommendationKey":"none","targetMeanPrice":2939.0907999999999,"numberOfAnalystOpinions":11,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:54:55.321716\", \"ticker\": \"4527\", \"ticker_full\": \"4527.T\", \"company_name\": \"ROHTO PHARMACEUTICAL CO\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 3, \"buy\": 4, \"hold\": 4, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 11, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 2388.5, \"high\": 3300.0, \"low\": 2300.0, \"mean\": 2939.0908, \"median\": 2950.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-08-06\", \"eps_estimate\": null, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2026-05-12\", \"eps_estimate\": 30.36, \"eps_actual\": 26.41, \"surprise_pct\": -13.01}, {\"date\": \"2026-02-11\", \"eps_estimate\": 44.11, \"eps_actual\": 47.03, \"surprise_pct\": 6.62}, {\"date\": \"2025-11-12\", \"eps_estimate\": 24.91, \"eps_actual\": 26.03, \"surprise_pct\": 4.5}, {\"date\": \"2025-05-12\", \"eps_estimate\": 24.96, \"eps_actual\": 27.38, \"surprise_pct\": 9.7}, {\"date\": \"2025-02-11\", \"eps_estimate\": 49.09, \"eps_actual\": 52.09, \"surprise_pct\": 6.11}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 10.99, \"institution_pct\": 31.82, \"major_holders\": [{\"label\": \"\", \"value\": 10.99}, {\"label\": \"\", \"value\": 31.82}, {\"label\": \"\", \"value\": 35.75}, {\"label\": \"\", \"value\": 145.0}], \"institutional_holders\": [{\"holder\": \"MFS SERIES TRUST X-MFS International Intrinsic Value Fund\", \"shares\": 10218000, \"date_reported\": \"2026-05-31\", \"pct_held\": 4.33, \"pct_change\": 0.0, \"value\": 24405693000}, {\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 2949444, \"date_reported\": \"2026-04-30\", \"pct_held\": 1.25, \"pct_change\": 0.06, \"value\": 7044746994}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 1985114, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.84, \"pct_change\": 3.29, \"value\": 4741444789}, {\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 1385700, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.59, \"pct_change\": 0.0, \"value\": 3309744450}, {\"holder\": \"Goldman Sachs TRT-Goldman Sachs Intl Small Cap Insights Fd.\", \"shares\": 982900, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.42, \"pct_change\": 1.98, \"value\": 2347656650}, {\"holder\": \"iShares Trust-iShares MSCI EAFE Small-Cap ETF\", \"shares\": 737300, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.31, \"pct_change\": -0.24, \"value\": 1761041050}, {\"holder\": \"EQ Advisors Trust-EQ\/MFS International Intrinsic Value Portfolio\", \"shares\": 650100, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.28, \"pct_change\": 3.08, \"value\": 1552763850}, {\"holder\": \"MFS Varbl INSURANCE TRT II-MFS Intl Intrinsic Value PORT.\", \"shares\": 639200, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.27, \"pct_change\": -2.4, \"value\": 1526729200}, {\"holder\": \"Mercer Funds-Mercer Non-US Core Equity Fund\", \"shares\": 618800, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.26, \"pct_change\": 2.03, \"value\": 1478003800}, {\"holder\": \"FPA FUNDS TRUST-FPA Crescent Fund\", \"shares\": 625500, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.26, \"pct_change\": -37.92, \"value\": 1494006750}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":25,"get_dividend_history_year2":41,"get_dividend_history_year3":31,"get_dividend_history_year4":24,"get_dividend_history_year5":20.5,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T03:03:14.636442\", \"ticker\": \"4527\", \"ticker_full\": \"4527.T\", \"company_name\": \"ROHTO PHARMACEUTICAL CO\", \"company_info\": {\"name_en\": \"ROHTO PHARMACEUTICAL CO\", \"long_name\": \"Rohto Pharmaceutical Co.,Ltd.\", \"sector\": \"Consumer Defensive\", \"industry\": \"Household & Personal Products\", \"website\": \"https:\/\/www.rohto.co.jp\", \"employees\": 9292, \"country\": \"Japan\", \"city\": \"Osaka\", \"address\": \"1-8-1 Tatsuminishi\", \"description\": \"Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 2811.8, \"deviation\": 1.95, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 2567.56, \"deviation\": 11.64, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 2460.03, \"deviation\": 16.52, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 2456.85, \"deviation\": 16.67, \"trend\": \"up\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 343725000000.0, \"revenue_fmt\": \"\u00a53437\u5104\", \"gross_profit\": 192695000000.0, \"gross_profit_fmt\": \"\u00a51927\u5104\", \"operating_income\": 41122000000.0, \"operating_income_fmt\": \"\u00a5411\u5104\", \"ebit\": 48105000000.0, \"ebit_fmt\": \"\u00a5481\u5104\", \"net_income\": 34247000000.0, \"net_income_fmt\": \"\u00a5342\u5104\", \"eps\": 145.29, \"operating_margin\": 11.96, \"total_assets\": 485771000000.0, \"total_assets_fmt\": \"\u00a54858\u5104\", \"total_equity\": 301826000000.0, \"total_equity_fmt\": \"\u00a53018\u5104\", \"total_debt\": 60244000000.0, \"total_debt_fmt\": \"\u00a5602\u5104\", \"total_cash\": 86816000000.0, \"total_cash_fmt\": \"\u00a5868\u5104\", \"equity_ratio\": 62.13, \"de_ratio\": 0.2, \"current_ratio\": 2.04, \"operating_cf\": 47788000000.0, \"operating_cf_fmt\": \"\u00a5478\u5104\", \"investing_cf\": -29780000000.0, \"investing_cf_fmt\": \"-\u00a5298\u5104\", \"financing_cf\": -11845000000.0, \"financing_cf_fmt\": \"-\u00a5118\u5104\", \"free_cf\": 21537000000.0, \"free_cf_fmt\": \"\u00a5215\u5104\", \"net_margin\": 9.96, \"roe\": 11.35, \"roa\": 7.05}, {\"year\": 2025, \"revenue\": 308625000000.0, \"revenue_fmt\": \"\u00a53086\u5104\", \"gross_profit\": 174393000000.0, \"gross_profit_fmt\": \"\u00a51744\u5104\", \"operating_income\": 38239000000.0, \"operating_income_fmt\": \"\u00a5382\u5104\", \"ebit\": 42575000000.0, \"ebit_fmt\": \"\u00a5426\u5104\", \"net_income\": 30841000000.0, \"net_income_fmt\": \"\u00a5308\u5104\", \"eps\": 134.72, \"operating_margin\": 12.39, \"total_assets\": 437039000000.0, \"total_assets_fmt\": \"\u00a54370\u5104\", \"total_equity\": 263371000000.0, \"total_equity_fmt\": \"\u00a52634\u5104\", \"total_debt\": 57409000000.0, \"total_debt_fmt\": \"\u00a5574\u5104\", \"total_cash\": 77161000000.0, \"total_cash_fmt\": \"\u00a5772\u5104\", \"equity_ratio\": 60.26, \"de_ratio\": 0.22, \"current_ratio\": 2.3, \"operating_cf\": 36917000000.0, \"operating_cf_fmt\": \"\u00a5369\u5104\", \"investing_cf\": -89170000000.0, \"investing_cf_fmt\": \"-\u00a5892\u5104\", \"financing_cf\": 35319000000.0, \"financing_cf_fmt\": \"\u00a5353\u5104\", \"free_cf\": 26356000000.0, \"free_cf_fmt\": \"\u00a5264\u5104\", \"net_margin\": 9.99, \"roe\": 11.71, \"roa\": 7.06}, {\"year\": 2024, \"revenue\": 270840000000.0, \"revenue_fmt\": \"\u00a52708\u5104\", \"gross_profit\": 157285000000.0, \"gross_profit_fmt\": \"\u00a51573\u5104\", \"operating_income\": 40052000000.0, \"operating_income_fmt\": \"\u00a5401\u5104\", \"ebit\": 41714000000.0, \"ebit_fmt\": \"\u00a5417\u5104\", \"net_income\": 30936000000.0, \"net_income_fmt\": \"\u00a5309\u5104\", \"eps\": 135.21, \"operating_margin\": 14.79, \"total_assets\": 346175000000.0, \"total_assets_fmt\": \"\u00a53462\u5104\", \"total_equity\": 246323000000.0, \"total_equity_fmt\": \"\u00a52463\u5104\", \"total_debt\": 10494000000.0, \"total_debt_fmt\": \"\u00a5105\u5104\", \"total_cash\": 89210000000.0, \"total_cash_fmt\": \"\u00a5892\u5104\", \"equity_ratio\": 71.16, \"de_ratio\": 0.04, \"current_ratio\": 2.47, \"operating_cf\": 34245000000.0, \"operating_cf_fmt\": \"\u00a5342\u5104\", \"investing_cf\": -16317000000.0, \"investing_cf_fmt\": \"-\u00a5163\u5104\", \"financing_cf\": -13784000000.0, \"financing_cf_fmt\": \"-\u00a5138\u5104\", \"free_cf\": 25333000000.0, \"free_cf_fmt\": \"\u00a5253\u5104\", \"net_margin\": 11.42, \"roe\": 12.56, \"roa\": 8.94}, {\"year\": 2023, \"revenue\": 238664000000.0, \"revenue_fmt\": \"\u00a52387\u5104\", \"gross_profit\": 137421000000.0, \"gross_profit_fmt\": \"\u00a51374\u5104\", \"operating_income\": 33964000000.0, \"operating_income_fmt\": \"\u00a5340\u5104\", \"ebit\": 34537000000.0, \"ebit_fmt\": \"\u00a5345\u5104\", \"net_income\": 26377000000.0, \"net_income_fmt\": \"\u00a5264\u5104\", \"eps\": 115.29, \"operating_margin\": 14.23, \"total_assets\": 309677000000.0, \"total_assets_fmt\": \"\u00a53097\u5104\", \"total_equity\": 209568000000.0, \"total_equity_fmt\": \"\u00a52096\u5104\", \"total_debt\": 11693000000.0, \"total_debt_fmt\": \"\u00a5117\u5104\", \"total_cash\": 79951000000.0, \"total_cash_fmt\": \"\u00a5800\u5104\", \"equity_ratio\": 67.67, \"de_ratio\": 0.06, \"current_ratio\": 2.37, \"operating_cf\": 30924000000.0, \"operating_cf_fmt\": \"\u00a5309\u5104\", \"investing_cf\": -13176000000.0, \"investing_cf_fmt\": \"-\u00a5132\u5104\", \"financing_cf\": -16199000000.0, \"financing_cf_fmt\": \"-\u00a5162\u5104\", \"free_cf\": 21016000000.0, \"free_cf_fmt\": \"\u00a5210\u5104\", \"net_margin\": 11.05, \"roe\": 12.59, \"roa\": 8.52}, {\"year\": 2022, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 20.5}, {\"year\": 2023, \"amount\": 24.0}, {\"year\": 2024, \"amount\": 31.0}, {\"year\": 2025, \"amount\": 41.0}, {\"year\": 2026, \"amount\": 25.0}], \"latest\": 25.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-7770","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ROHTO PHARMACEUTICAL CO - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4527\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4527\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4527\/\",\"name\":\"ROHTO PHARMACEUTICAL CO - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2025-12-22T06:27:04+00:00\",\"dateModified\":\"2026-08-23T04:13:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4527\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4527\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4527\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ROHTO PHARMACEUTICAL CO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ROHTO PHARMACEUTICAL CO - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4527\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4527\/","url":"https:\/\/japanir.jp\/en\/company\/company-4527\/","name":"ROHTO PHARMACEUTICAL CO - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2025-12-22T06:27:04+00:00","dateModified":"2026-08-23T04:13:07+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4527\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4527\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4527\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"ROHTO PHARMACEUTICAL CO"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/7770","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=7770"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=7770"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}